Who owns ACTUATE THERAPEUTICS INC?
- Ticker: ACTU
- CUSIP Number: 005083100
Tip: Access positions for across all investors
Analyze quarterly positions in Actuate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actuate Therapeutics stock
Who bought or sold ACTUATE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BIOS Capital Management | 10M | $67M | 1% | Sep 2025 |
|
| Voss Capital | 896k | $6.0M | 213% | Sep 2025 |
|
| Vanguard Group | 316k | $2.1M | 19% | Sep 2025 |
|
| BlackRock | 282k | $1.9M | 44% | Sep 2025 |
|
| Geode Capital Management | 145k | $973k | 23% | Sep 2025 |
|
| Northern Trust | 86k | $572k | 0% | Sep 2025 |
|
| State Street Corporation | 50k | $334k | 59% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 19k | $129k | 4% | Sep 2025 |
|
| Gleason Group | 19k | $127k | 0% | Sep 2025 |
|
| SFMG Wealth Advisors | 17k | $114k | 17% | Sep 2025 |
|
| LPL Financial | 16k | $109k | -13% | Sep 2025 |
|
| Charles Schwab Investment Management | 15k | $99k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 14k | $91k | 6% | Sep 2025 |
|
| Royal Bank of Canada | 13k | $0 | 876% | Sep 2025 |
|
| Freestone Capital Holdings | 10k | $67k | 0% | Sep 2025 |
|
| UBS Group | 8.9k | $60k | 280% | Sep 2025 |
|
| Barclays | 8.9k | $59k | -76% | Sep 2025 |
|
| Rhumbline Advisers | 8.8k | $59k | -3% | Sep 2025 |
|
| Morgan Stanley | 7.7k | $47k | 100% | Jun 2025 |
|
| Northwestern University | 6.5k | $43k | -77% | Sep 2025 |
|
| Global Retirement Partners | 6.3k | $42k | 0% | Sep 2025 |
|
| New York State Common Retirement Fund | 6.2k | $42k | -64% | Sep 2025 |
|
| Sontag Advisory | 5.0k | $34k | 100% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 2.7k | $18k | -16% | Sep 2025 |
|
| Jpmorgan Chase & Co | 2.5k | $17k | 100% | Sep 2025 |
|
| Tower Research Capital | 1.6k | $11k | 12538% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.6k | $10k | 72% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 1.3k | $8.4k | -88% | Sep 2025 |
|
| Advisor Group Holdings | 1.0k | $8.4k | 0% | Sep 2025 |
|
| Prosight Management | 885.00 | $5.9k | 100% | Sep 2025 |
|
| Legal & General Group | 708.00 | $4.7k | 0% | Sep 2025 |
|
| Summit Investment Advisors | 601.00 | $4.0k | 0% | Sep 2025 |
|
| FMR | 573.00 | $3.8k | 84% | Sep 2025 |
|
| Russell Investments | 487.00 | $3.3k | 100% | Sep 2025 |
|
| Pnc Financial Services | 384.00 | $2.6k | 100% | Sep 2025 |
|
| California State Teachers Retirement System | 368.00 | $2.5k | 0% | Sep 2025 |
|
| Amalgamated Bank | 201.00 | $999.995100 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 70.00 | $470.911000 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 60.00 | $400.998000 | 100% | Sep 2025 |
|
| CWM | 51.00 | $0 | 100% | Sep 2025 |
|
| Sterling Capital Management | 15.00 | $100.000500 | 7% | Sep 2025 |
|
Who sold out of Actuate Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Mar 2025 | 22k | $151k |
| Chicago Partners Investment | Jun 2025 | 10k | $68k |
| Tang Capital Management | Jun 2025 | 5.2k | $32k |